Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven with ClinOleic, Lipoplus, or SMOFlipid in HPN
NCT03149653Phase 4Completed
- Sponsor
- General University Hospital in Prague
- Start
- Jan 2012
- Primary completion
- Jan 2016
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in intestinal failure (IF), sponsored by General University Hospital in Prague. Started Jan 2012; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
intestinal failure (IF)
Beyond the preview
Go deeper on NCT03149653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03149653.